Rivaroxaban Consumption Outcome in SARS-CoV-2 Pneumonia

Abstract

Background: SARS-COV-2 is one of prothrombotic illness, and this raise mortality and
morbidity. Rivaroxaban is one of antithrombotic agent helpful in reducing SARS-COV-2
morbidity and mortality. The study aimed to assess the effectiveness of early administration of
Rivaroxaban in reducing SARS-COV-2 mortality.
Method: A cross-sectional observational study was d